40O - Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with advanced breast cancer (ABC): Final results from EVEREXES
| Autor: | Im, Y.-H., Karabulut, B., Lee, K.S., Adhav, A., Park, B.-W., Yesil Cinkir, H., Bowles, J., Delgar Alfaro, T, Xue, H.L., Kim, S.-B. |
|---|---|
| Zdroj: | In Annals of Oncology November 2019 30 Supplement 9:ix15-ix15 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|